Virbac: 2025 Half-year results

Financial Performance - The company reported revenues of €738.3 million for the first half of 2025, representing a 5.0% increase compared to €702.9 million in the same period of 2024. At constant exchange rates, revenue growth was 7.8% [1][7] - Current operating profit before amortization of assets from acquisitions decreased to €135.0 million, down 10.2% from €150.4 million in the first half of 2024, resulting in a margin of 18.3% of revenue [1][9] - Consolidated net income fell to €82.2 million, a decrease of 13.3% compared to €94.9 million in the first half of 2024 [1][10] Growth Drivers - The integration of Sasaeah, acquired in April 2024, contributed 2.2 percentage points to revenue growth. Organic growth at constant exchange rates and scope reached 5.6%, driven by a volume increase of approximately 2.1 points and price growth of about 3.5 points [7][8] - Regional performance varied, with Europe achieving a notable growth of 7.1% at constant exchange rates, particularly in Western Europe with a 9.4% increase, while North America grew by 5.9% [8] Financial Outlook - The company confirmed its 2025 revenue growth target of 4% to 6% at constant rates and scope, with the Sasaeah acquisition expected to contribute an additional 1 percentage point to growth [3][13] - The ratio of adjusted recurring operating income to revenue is anticipated to stabilize around 16% for 2025, reflecting ongoing investments in R&D [3][13] Debt and Cash Flow - As of June 30, 2025, net debt was reported at €201.4 million, a reduction of 21.0% from €254.9 million in the previous year [1][12] - Operating cash flow before interest and taxes was €164.0 million, down 5.0% from €172.6 million in the first half of 2024 [1][5]